Ginkgo Bioworks today announced that they had expanded their support for the U.S. Centers for Disease Control and Prevention's (CDC) Traveler-based Genomic Surveillance (TGS) program to include a study monitoring influenza viruses.
Traveler-based pathogen monitoring represents a novel approach to influenza surveillance, complementing CDC's ongoing efforts by providing early insights into global trends in influenza virus evolution.
Read More
